TDXR FLECAINIDE— 510(k) K872175

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K872175 for TDXR FLECAINIDE, Substantially Equivalent on 1987-08-13. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LBZ
Advisory panel: Clinical Toxicology
Date received: 1987-06-08
Decision date: 1987-08-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.